Is Avadel Pharmaceuticals PLC (AVDL) Stock at the Top of the Drug Manufacturers

The 67 rating InvestorsObserver gives to Avadel Pharmaceuticals PLC (AVDL) stock puts it near the top of the Drug Manufacturers - Specialty & Generic industry. In addition to scoring higher than 91 percent of stocks in the Drug Manufacturers - Specialty & Generic industry, AVDL’s 67 overall rating means the stock scores better than 67 percent of all stocks.

AVDL has an Overall Score of 67. Find out what this means to you and get the rest of the rankings on AVDL!

See Full AVDL Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 67 means the stock is more attractive than 67 percent of stocks. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Avadel Pharmaceuticals PLC Stock Today?

Avadel Pharmaceuticals PLC (AVDL) stock has fallen -2.24% while the S&P 500 is higher by 0.85% as of 11:28 AM on Thursday, Mar 7. AVDL has fallen -$0.36 from the previous closing price of $16.32 on volume of 208,891 shares. Over the past year the S&P 500 has risen 28.97% while AVDL is higher by 67.65%. AVDL lost -$2.00 per share the over the last 12 months. Click Here to get the full Stock Report for Avadel Pharmaceuticals PLC stock.